However, its function and underlying mechanisms in NSCLC EGFR-TKI resistance remain unclear; furthermore, whether VDR is involved in the capacity of 1,25-dihydroxyvitamin D3 to counteract EGFR-TKI resistance in NSCLC warrants further investigation. The gene discussed is VDR; the disease is non-small cell lung carcinoma.